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In observational studies of the general population, higher body mass index (BMI) has been
associated with increased incidence of and mortality from bloodstream infection (BSI) and
sepsis. On the other hand, higher BMI has been observed to be apparently protective
among patients with infection and sepsis. We aimed to evaluate the causal association of
BMI with risk of and mortality from BSI.
Methods and findings
We used a population-based cohort in Norway followed from 1995 to 2017 (the Trøndelag
Health Study [HUNT]), and carried out linear and nonlinear Mendelian randomization analy-
ses. Among 55,908 participants, the mean age at enrollment was 48.3 years, 26,324
(47.1%) were men, and mean BMI was 26.3 kg/m2. During a median 21 years of follow-up,
2,547 (4.6%) participants experienced a BSI, and 451 (0.8%) died from BSI. Compared with
a genetically predicted BMI of 25 kg/m2, a genetically predicted BMI of 30 kg/m2 was associ-
ated with a hazard ratio for BSI incidence of 1.78 (95% CI: 1.40 to 2.27; p < 0.001) and for
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BSI mortality of 2.56 (95% CI: 1.31 to 4.99; p = 0.006) in the general population, and a haz-
ard ratio for BSI mortality of 2.34 (95% CI: 1.11 to 4.94; p = 0.025) in an inverse-probability-
weighted analysis of patients with BSI. Limitations of this study include a risk of pleiotropic
effects that may affect causal inference, and that only participants of European ancestry
were considered.
Conclusions
Supportive of a causal relationship, genetically predicted BMI was positively associated with
BSI incidence and mortality in this cohort. Our findings contradict the “obesity paradox,”
where previous traditional epidemiological studies have found increased BMI to be appar-
ently protective in terms of mortality for patients with BSI or sepsis.
Author summary
Why was this study done?
• It is well-recognized that overweight and obesity are associated with increased risk of
bloodstream infection (BSI) and sepsis, but it is not fully understood whether this is due
to body weight in itself or factors related to body weight (such as exercise or smoking
habits).
• While a large number of studies have observed that BSI or sepsis patients who are over-
weight or obese have a reduced risk of dying from those diseases, there is reason to sus-
pect that these findings are biased.
• We wanted to evaluate whether genetically predicted body mass index (BMI)—which is
independent of lifestyle factors—was associated with risk of developing and dying from
a BSI.
What did the researchers do and find?
• We used clinical and genetic information from the Trøndelag Health Study in Norway
on 55,908 participants representative of the adult Norwegian population.
• Similar to what has been found in non-genetic studies, we found that increased geneti-
cally predicted BMI was associated with an increased risk of developing a BSI.
• Contrary to many observational studies, we found that among BSI patients, being over-
weight or obese was associated with an increased risk of death from bloodstream
infection.
What do these findings mean?
• The findings of many previous observational studies of an apparently protective effect
of overweight or obesity among patients with BSI or sepsis may be affected by other fac-
tors, such as accompanying characteristics of overweight or obese individuals, or by
who ends up participating in the studies.
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• In this cohort, higher genetically predicted BMI was associated with an increased risk of
developing and dying from a BSI, also among BSI patients, and our findings support the
worldwide initiative to reduce the prevalence of overweight and obesity.
Introduction
Bloodstream infection (BSI) is caused by bacteria entering the bloodstream as a severe compli-
cation of an infection, and may in turn lead to sepsis, representing a dysregulated immune
response to infection resulting in organ dysfunction and high mortality rate [1]. BSI is a com-
mon cause of death globally [2–4]. It is therefore important to identify factors that may reduce
the risk of developing and dying from BSI.
Obesity is increasingly common worldwide [5], and is associated with greater risk of a wide
range of diseases and all-cause mortality [6]. Traditional observational studies of general popu-
lations have found body mass index (BMI) to be positively associated with risk of BSI or sepsis
[7–10], and above-normal BMI to be associated with BSI or sepsis mortality [7,9,11]. However,
studies restricted to patients with BSI or sepsis have observed a considerable reduced mortality
risk with increasing BMI [12–17], including a systematic review from 2017 [18]. It has there-
fore been advocated that one should study in what way obesity is protective for sepsis mortal-
ity, and that this may help inform new therapeutic strategies [17,18]. This counterintuitive
reduction in disease progression or mortality among overweight and obese patients with a par-
ticular disease has been termed the “obesity paradox” and has been observed for other illnesses
such as type 2 diabetes [19].
Some argue that the paradox may be explained by systematic error, and there has been a
call for more rigorous studies to establish causal relationships [20–22]. There are 3 main areas
of concern: selection bias, reverse causation, and confounding. If obesity is associated with BSI
risk, nonobese patients may have other characteristics that caused their BSI that in turn are
more strongly associated with mortality. This selection bias may make obesity appear protec-
tive in studies of mortality rate among all patients with BSI or sepsis [23]. Reverse causation
may arise if measured BMI is affected by BSI (e.g., dehydration). Importantly, there may be
confounding from factors such as chronic diseases and smoking habits that affect both BMI
and BSI mortality. Mendelian randomization (MR) studies mimic randomized trials using
genetic data as instruments for exposures. MR leverages information on genetic variants that
segregate randomly at conception. If people with a genetic risk of being overweight or obese
also have an increased risk of developing and dying from BSI, a causal relationship between
BMI and mortality from BSI is strengthened (i.e., the relationship is likely independent of con-
founders and not subject to reverse causation) [24].
The aim of this study was to assess the causal association between BMI and risk of and mor-
tality from BSI. We sought to overcome the limitations of the observational studies mentioned
above by conducting an MR study in a general population of approximately 56,000 partici-
pants in Norway with 23 years of follow-up.
Methods
This study is reported according to the preprint guideline for reporting of MR studies, STRO-
BE-MR (S1 Checklist) [25] and the STROBE guideline for cohort studies (S2 Checklist) [26].
The Trøndelag Health Study (HUNT) is a series of cross-sectional surveys carried out in
Nord-Trøndelag County, Norway. The county consists of 130,000 inhabitants, and is
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representative of the general adult Norwegian population in terms of morbidity, mortality,
sources of income, and age distribution [27]. The present study was based on the HUNT2 sur-
vey conducted in 1995–1997, to which 93,865 people were invited, and 65,236 (69.5%)
participated.
Background characteristics such as age, sex, smoking status (current, former, never), life-
style factors, education level, activity level, anthropometric measures, and self-reported history
of cancer were collected once for each participant in the HUNT2 survey. Height and weight
were measured by trained staff, and BMI calculated as weight in kilograms divided by the
squared height in meters.
The personal identification number of Norwegian citizens was used to link the study popu-
lation to all prospectively recorded blood cultures at the 2 community hospitals in the catch-
ment area (Levanger and Namsos Hospitals), as well as St. Olavs Hospital in Trondheim,
which serves as a tertiary referral center. Data on blood cultures were available from 1 January
1995 (from 1 September 1999 in Namsos Hospital) through the end of 2017. Dates of death
and emigration out of Nord-Trøndelag County were obtained from the Norwegian population
registry.
BSI was defined as positive blood culture of pathogenic bacteria, excluding bacteria such as
Corynebacterium species, Propionibacterium species, and coagulase-negative Staphylococcus
species often associated with blood culture contamination [28]. BSI mortality was defined as
death within 30 days of BSI diagnosis.
Participants were followed until death or emigration out of Nord-Trøndelag, or to the end
of December 2017.
Details about genotyping and imputation are provided in S1 Text. After sample and variant
quality control, imputation was completed for 61,412 patients, all of European ancestry.
The genetic risk score (GRS) for BMI was calculated based on 939 of 941 near-independent,
single nucleotide polymorphisms (SNPs; p< 1 × 10−8) identified as related to BMI in a meta-
analysis of approximately 700,000 individuals (rs498240 and rs3819299 did not pass imputa-
tion quality control) [29].
Among patients with genotype data, BMI was available for 55,944. One participant was
excluded due to outlying weight/height ratio. Participants who had a registered BSI before par-
ticipating in the HUNT2 survey were excluded (n = 35). The final study sample consisted of
55,908 participants.
No protocol was written for this particular study, but the aims of the study were formalized
prior to the analyses being conducted. The only substantial changes to the analyses were the
addition of 2-sample MR analyses as suggested by peer-reviewers.
Statistical analysis
The a priori main outcome of this MR study was the association between genetically predicted
BMI and BSI mortality in the general population, while secondary analyses were MR analyses
of association between genetically predicted BMI and (1) BSI incidence, (2) BSI incidence and
mortality stratified by sex, and (3) BSI mortality among patients with BSI. Unless stated other-
wise, the results presented in this study are evaluating the effect of genetically predicted BMI
(as opposed to observed BMI).
The GRS for BMI was calculated by use of the “—score” command in PLINK (version 1.9),
weighted based on the effect estimates from the meta-analysis by Yengo et al. [29]. We esti-
mated the association between the GRS and BMI by use of linear regression, and between the
GRS and risk of BSI or BSI mortality by use of Cox proportional hazards regression. Both
models accounted for age and sex.
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As previous studies have suggested a nonlinear association between BMI and BSI incidence
and mortality [9], we fitted a fractional polynomial model as described elsewhere [30] and in
S1 Text. In analyses assuming a linear relationship between exposure and outcome, we used
the 2-stage least squares method with sandwich estimator for the error terms in the second
stage [31]. In the MR analysis of the effect of BMI on BSI mortality among patients with BSI,
day 0 was set to day of BSI diagnosis, and participants were followed for 30 days. To account
for potential selection bias, we weighted participants from the total study population by the
inverse probability of developing BSI, calculated based on the GRS, BMI, age, sex, history of
cancer, smoking status, physical activity, and education [32]. The weighting was trimmed at
the 99th percentile. This analysis was compared to an MR analysis without inverse probability
weighting (IPW) and a similar traditional multivariable analysis adjusting for age, sex, history
of cancer, smoking status, physical activity, and education.
Three main assumptions must be met for an MR study to be valid: (1) There is an associa-
tion between the genetic instrument and the exposure; (2) the genetic instrument is not associ-
ated with the outcome other than through the exposure; and (3) the genetic instrument is not
associated with confounders of the exposure–outcome association [24]. We performed a range
of sensitivity analyses: (1) an analysis of the linear association between the GRS and BMI; (2)
an analysis of the association between quartiles of the GRS and predefined confounders (due
to signs of pleiotropic effects on smoking habits, the main analysis was run among never-
smokers and then among previous or current smokers); (3) an MR analysis of BSI mortality in
the general population restricted to near-independent SNPs associated with the FTO gene
(robustly associated with BMI) [33]; (4) MR-Egger regression (random effects), inverse-vari-
ance-weighted (IVW) regression (random effects), and weighted median estimator analysis
[34], assuming a linear relationship between BMI and BSI mortality in the general population;
(5) comparison of analyses from the previous point with the same analyses conducted in a
2-sample design, using SNP–exposure associations from Yengo et al. [29] and SNP–outcome
associations from HUNT (methods described in S1 Text); (6) comparison of our main MR
analysis of BSI mortality in the general population with comparable traditional Cox regression
adjusting for age, sex, history of cancer, smoking, physical activity, and education; and (7) rep-
etition of the main analysis after adjustment for 5 ancestry-informative principal components
computed by use of LASER v2.04 to account for potential population stratification [35].
Signs of selection bias were explored by restricting the study population to participants with
BSI. We compared values of confounders for individuals in the highest BMI quartile (Q4) to those
for individuals in the lowest BMI quartile (Q1) among patients with BSI, and compared this ratio
(Q4/Q1) or difference (Q4 − Q1) with the concordant comparison in the total study population.
Finally, we did an MR sensitivity analysis stratified on whether the BSI was due to gram-
positive or gram-negative bacteria.
R (version 3.4.1; packages metafor, ggplot2, gtools, Hmisc, ipw, lm.beta, sandwich, survey,
survival, timereg, and lmtest) and Stata/SE 15.1 (College Station, TX, US; package mrrobust)
were used.
Ethical approval
The Regional Committee for Medical Research, Health Region IV, in Norway approved HUNT,
and this project is regulated in conjunction with Norwegian Social Science Data Services.
Results
A total of 55,908 participants were followed for a median of 21 years, amounting to 995,474
person-years. There were 2,547 (4.6%) first occurrences of BSI, and 451 (0.8% of total, 17.7%
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of BSIs) deaths attributed to BSI. Participants who contracted a BSI or died from BSI were
older, were more likely to be male and to be smokers, were less physically active and less edu-
cated, and had higher prevalence of self-reported history of cancer at study enrollment
(Table 1).
The GRS explained 4.2% of the variation of BMI in our population (F-statistic = 2,461).
There was a strong positive association between genetically predicted BMI and BSI incidence
and mortality in the general population (Figs 1 and 2). A genetically predicted BMI of 20 kg/
m2, 30 kg/m2, and 35 kg/m2—compared with 25 kg/m2—was associated with a hazard ratio
(HR) for BSI incidence of 0.99 (95% confidence interval [CI]: 0.69 to 1.42; p = 0.960), 1.78
(95% CI: 1.40 to 2.27; p< 0.001), and 3.60 (95% CI: 2.18 to 5.93; p< 0.001), and for BSI mor-
tality of 0.68 (95% CI: 0.48 to 0.96; p = 0.029), 2.56 (95% CI: 1.31 to 4.99; p = 0.006), and 8.57
(95% CI: 2.26 to 32.53; p = 0.002), respectively. Fig 1 and Fig 2 show tendencies of J-shaped
associations, but are also compatible with linear relationships. A 1-kg/m2 increase in geneti-
cally predicted BMI increased the risk of contracting BSI by 10% (95% CI: 5% to 16%;
p< 0.001) and the risk of dying from BSI by 19% (95% CI: 6% to 33%; p = 0.003).
In the IPW analysis restricted to patients with BSI, we observed that a 1-kg/m2 increase in
genetically predicted BMI was associated with a non-statistically significant increased risk of
BSI mortality of 11% (95% CI: −1% to 24%; p = 0.069). Genetically predicted BMI of 30 kg/m2,







Age (years)§ 48.3 (36.5–62.3) 63.6 (52.9–71.4) 67.3 (57.1–74.5)
Male sex� 26,324 (47.1) 1,345 (52.8) 263 (58.3)
BMI (kg/m2)^ 26.3 (4.1) 27.7 (4.5) 27.9 (4.8)
Median follow-up time (years)§ 21.1 (17.1–21.8) 13.8 (8.4–18.3) 13.3 (7.7–17.9)
Self-reported cancer� 1,955 (3.7) 144 (6.2) 24 (5.9)
Smoking�
Never 23,594 (43.0) 876 (35.2) 156 (35.6)
Previous 15,133 (27.6) 893 (35.8) 164 (37.4)
Current 16,117 (29.4) 723 (29.0) 118 (26.9)
Physical activity�
None 3,821 (7.6) 243 (11.9) 54 (15.4)
Slight 15,662 (31.0) 714 (34.9) 117 (33.3)
Moderate 17,167 (34.0) 693 (33.9) 116 (33.1)
High 13,810 (27.4) 397 (19.4) 64 (18.2)
Education�
�9 years 19,033 (35.7) 1,305 (55.8) 240 (58.8)
10–12 years 23,468 (44.0) 762 (32.6) 125 (30.6)
�13 years 10,832 (20.3) 274 (11.7) 43 (10.5)
BMI, body mass index; BSI, bloodstream infection. Data are presented as
^mean (standard deviation)
§median (25th–75th percentiles), or
�n (%). BSI incidence is based on first occurrence; otherwise, last occurrence is used. Education defined as follows:�9 years (“primary school 7–10 years, continuation
school, folk high school”), 10–12 years (“high school, intermediate school, vocational school, 1–2 years high school” and “university qualifying examination, junior
college, A levels”), and�13 years (“university or other post-secondary education, less than 4 years” and “university/college 4 years or more”). Activity defined as follows:
none (“no light or vigorous activity”), slight (“<3 h light activity/week and no vigorous activity”), moderate (“�3 h light activity/week or <1 h vigorous activity/week”),
or high (“�1 h vigorous activity/week”).
https://doi.org/10.1371/journal.pmed.1003413.t001
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compared with 25 kg/m2, was associated with a HR for mortality of 2.34 (95% CI: 1.11 to 4.94;
p = 0.025) (Fig 3). For comparison, a 1-kg/m2 increase in BMI in the non-IPW MR analysis
was associated with an increase in BSI mortality risk of 12% (95% CI: 1% to 25%; p = 0.039),
and in the non-IPW traditional multivariable Cox regression model, it was associated with a
non-statistically significant increase in mortality risk of 2% (95% CI: −1% to 5%; p = 0.188).
The sex-stratified associations between BMI and BSI incidence and mortality in the general
population are presented in S1 and S2 Figs, respectively.
Sensitivity analyses
The traditional Cox regression model provided a weaker association between BMI and BSI
incidence and mortality in the general population compared with the MR analysis (S1 and S2
Tables).
The results were unchanged after adjustment for 5 ancestry-informative principal compo-
nents; in other words, there were no signs of population stratification (S3 Fig). When using
only SNPs associated with the FTO gene to calculate the GRS, which explained 0.4% of BMI
variation (F-statistic = 218), the results were consistent, though with wider CIs (S4 Fig).
Potential confounders were tabulated against BMI quartiles (S3 Table) and GRS quartiles
(S4 Table). BMI was positively associated with self-reported history of cancer, never-smoking
status, and age, and negatively associated with current smoking status, education, and physical
activity. For the GRS, there was a positive association with current smoking status, while the
other confounders were minimally associated (R2 < 0.1%). Sensitivity analyses of never-smok-
ers and ever-smokers yielded the same association between BMI and BSI mortality as in the
main analysis (S5 Fig).
MR-Egger regression supported a causal association between BMI and BSI mortality in the
general population adjusted for directional pleiotropy (HR = 1.18; 95% CI: 1.04 to 1.33;
p = 0.011), and the average pleiotropic effect of the SNPs was null (HR = 1.00; 95% CI: 0.99 to
1.00; p = 0.476) (S5 Table; S6 Fig) [34]. We observed similar findings using the IVW method
and weighted median estimator (p = 0.002 and p = 0.081, respectively). The comparable analy-
ses in a 2-sample design yielded a similar association between BMI and risk of dying from BSI
in the general population: The odds ratios in MR-Egger regression, IVW regression, and
weighted median estimator analysis for a one standard deviation increase of BMI were 1.98
(95% CI: 0.95 to 4.18; p = 0.070), 1.89 (95% CI: 1.33 to 2.67; p< 0.001), and 2.09 (95% CI: 1.10
to 3.97; p = 0.025), respectively (S5 Table).
Evaluating signs of selection bias, we found that BSI patients in the highest BMI quartile,
compared with those in the lowest quartile, were less likely to report a history of cancer,
which was not the case in the general population (S6 Table). When we examined partici-
pants who would eventually develop BSI, participants in the highest BMI quartile—relative
to those in the lowest BMI quartile—had a lower prevalence of risk factors and a higher
prevalence of protective factors, compared with the concordant prevalences in the general
population.
Among the underweight and normal weight participants (BMI < 25 kg/m2), genetically
predicted BMI was more strongly associated with BSI mortality in the general population for
gram-positive infections than gram-negative infections (S7 Fig), but there were no differences
among the overweight and obese participants.
Fig 1. Mendelian randomization analysis of body mass index and bloodstream infection incidence. The association between genetically predicted
body mass index and risk of contracting a bloodstream infection (BSI), with a body mass index of 25 kg/m2 as reference (red dot). Gray lines represent
95% confidence intervals.
https://doi.org/10.1371/journal.pmed.1003413.g001
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Discussion
This MR study shows a positive association between genetically predicted BMI and BSI mor-
tality, both in the general population and among patients with BSI, opposing the obesity para-
dox. Similarly, genetically predicted BMI was positively associated with BSI incidence.
In several studies, overweight and obese participants have been found to be at an increased
risk of developing sepsis or BSI [7–10]. One of these studies also performed MR analyses of
BMI and population risk of developing sepsis, but found no association, which may be due to
the use of a weak genetic instrument [10]. Three recent population-based studies found over-
weight [7] and obese [7,9] participants to be at increased risk of BSI mortality, or observed a
positive association between BMI and BSI mortality [11]. However, these observational studies
may be affected by reverse causation and residual confounding.
The present study used a similar study population to that of Paulsen et al. [9], but had 6
more years of follow-up, 9,000 fewer participants (due to dependence on genotyping), and 55
(14%) more deaths due to BSI [9]. While Paulsen et al. found that BSI mortality risk started to
increase at around BMI 30 kg/m2, we found it to start to increase at around 20 kg/m2. This
observed difference is likely because the MR design has accounted for residual negative con-
founding. Our study found a stronger association between BMI and BSI mortality than the 2
other population-based studies [7,11]. MR estimates represent the impact of long-term differ-
ences in the trajectory of a risk factor over the life course; this impact is likely to differ from the
impact of short-term interventions on the risk factor. Additionally, with a binary outcome, the
estimates are marginal across covariates, and hence will differ from estimates from a multivari-
able-adjusted regression [36].
Our findings are in line with experimental animal studies of obesity and sepsis mortality
[37]. However, human observational studies restricted to patients with sepsis or BSI have con-
sistently found that there is a reduced risk of sepsis or BSI mortality among overweight and
obese patients [18]. A systematic review from 2017 found markedly reduced mortality from
sepsis among overweight and obese patients compared with those of normal weight [18].
Other hospital-based studies have reported similar findings [12–15], including a recent study
of approximately 55,000 patients from 139 hospitals in the United States [17].
However, all of these hospital-based studies are likely affected by selection bias, in addition
to possible reverse causation and confounding [38,39]. Similarly, when we restricted our study
population to those that would develop BSI, the risk of BSI mortality among participants in the
highest BMI quartile was reduced. Adjustment for introduced selection bias will often be
insufficient [40].
One way to reduce selection bias is to use IPW [32]. In our IPW analysis of BSI patients, we
observed a positive association between genetically predicted BMI and mortality similar to
that of the total study population, albeit somewhat weaker. The finding of the comparable
unweighted MR analysis was similar to that of the weighted one, which is supported by simula-
tions that show that moderate selection bias will only lead to slight bias in a typical MR analysis
[32]. Additionally, we observed a stronger association between BMI (both genetically predicted
and observed) and BSI mortality in the general population than between BMI and BSI inci-
dence, which would be expected if BMI increases BSI mortality risk among BSI patients.
In terms of the MR assumptions, assumption 1 was met as there was a strong association
between the GRS and the exposure. Smoking was unevenly distributed at different levels of the
Fig 2. Mendelian randomization analysis of body mass index and bloodstream infection mortality in the general population. The association
between genetically predicted body mass index and risk of dying from a bloodstream infection (BSI) in the general population, with a body mass index
of 25 kg/m2 as reference (red dot). Gray lines represent 95% confidence intervals.
https://doi.org/10.1371/journal.pmed.1003413.g002
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Fig 3. Mendelian randomization analysis of body mass index and bloodstream infection mortality among patients with bloodstream infection.
The association between genetically predicted body mass index and risk of dying from a bloodstream infection (BSI) among patients with a
PLOS MEDICINE Body mass index and bloodstream infection mortality
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GRS, potentially violating assumption 3. However, in analyses stratified by smoking status, we
observed the same finding as in our main analysis. Additionally, assumption 2 was strength-
ened by MR-Egger regression, IVW regression, median estimator analysis, and the analysis
restricted to the FTO gene as instrument. In the 2-sample sensitivity analysis, the linear associ-
ation between BMI and risk of dying from a BSI in the general population was similar, albeit
with less precision, compared with the 1-sample analyses. The larger standard errors suggest
heterogeneity between the populations used by Yengo et al. [29] and in this study.
Strengths and limitations
To our knowledge, this is the first study to date to evaluate the association between BMI and risk
of dying from BSI or sepsis using an MR design. This allows us to assess an association that is
much less susceptible to reverse causation and unmeasured confounding than traditional obser-
vational studies. The MR design and IPW based on pre-disease background characteristics in
the analysis of BSI mortality among BSI patients reduces the risk of selection bias. The genetic
instrument for BMI that we used has been successfully applied in other recently published MR
studies [41,42]. Importantly, although it is recommended that researchers create the genetic
instrument based on the full set of SNPs associated with the desired exposure, this may increase
the risk of pleiotropic effects and affect causal inference [24]. We therefore conducted a wide
range of suggested sensitivity analyses [24], which supported that our findings were not mean-
ingfully affected by pleiotropy. MR-Egger regression may be biased and affected by residual con-
founding when applied in a 1-sample setting [43]; however, in our 2-sample analyses we
observed consistent results across the different sensitivity analyses. As the instruments were
selected from an independent sample, our MR analyses will tend not to be affected by winner’s
curse [44]. We assumed the phenotype–disease association to be log-linear, which may bias the
instrumental variable estimate depending on the properties of unmeasured confounders [45];
the non-instrumental variable analyses yielded similar but weaker associations. Given that we
used a homogenous population of participants of northern European ancestry, the risk of popu-
lation stratification is reduced, and it increases the precision of the GRS, which was based on a
genome-wide association study of individuals of similar ancestry [29]. We encourage replication
of our study in non-European cohorts to evaluate the generalizability of our findings to other
populations. The vast majority of patients with BSI have sepsis, but not all patients with sepsis
will have a positive blood culture [46]. Through record linkage with all hospitals in the region of
interest, we had complete information on all relevant BSI occurrences. However, while blood
culture tests are the gold standard to diagnose BSI, the sensitivity ranges between 10% and 50%,
which may have reduced the statistical power in our study [47]. We overcame the issue of power
by following approximately 56,000 participants representative of the adult Norwegian population
for 23 years. Finally, we were able to allow for potential nonlinear associations between the expo-
sure and the outcome, which has previously been challenging in MR studies [30].
Conclusion
In this Norwegian population-based cohort using an MR design, we found that any increase in
genetically predicted BMI increased the risk of both BSI incidence and BSI mortality in the
general population. Importantly, in an IPW MR analysis additionally accounting for selection
bias, we found that increased genetically predicted BMI increased the risk of mortality also
bloodstream infection, with a body mass index of 25 kg/m2 as reference (red dot). The analysis was weighted for the inverse probability of contracting a
bloodstream infection. Gray lines represent 95% confidence intervals.
https://doi.org/10.1371/journal.pmed.1003413.g003
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among patients with BSI, opposing the obesity paradox. While other researchers have sug-
gested that the “protective” effect of high BMI among patients with severe infectious diseases
may help inform new therapeutic strategies [17,18], our findings do not encourage such initia-
tives. Given the steady, worldwide increase of mean BMI among adults, and that BSI is a com-
mon cause of death, these findings strongly support interventions to reduce the prevalence of
overweight and obesity [2,5]. The efficacy of such interventions on the incidence of and mor-
tality from BSI should then be studied.
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